전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
· jei sergate amiotrofine lateraline skleroze.
will receive the injection· if you suffer from a disease called amyotrophic lateral sclerosis.
마지막 업데이트: 2008-03-04
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
· pacientams, sergantiems amiotrofine lateraline skleroze arba kitomis ligomis,
· in patients suffering from amyotrophic lateral sclerosis or other diseases which result in
마지막 업데이트: 2008-03-04
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
rilutek gydomi amiotrofine šonine skleroze (aŠs) sergantys pacientai.
rilutek is used in patients with amyotrophic lateral sclerosis (als).
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
rilutek skirtas pacientams, sergantiems sonine amiotrofine skleroze (sas) .
rilutek is used in patients with amyotrophic lateral sclerosis (als) .
마지막 업데이트: 2008-03-04
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
riluzole zentiva gydomi amiotrofine lateraline skleroze (als) sergantys pacientai.
riluzole zentiva is used in patients with amyotrophic lateral sclerosis (als).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
gydytojas skyr rilutek nuo nerv sistemos ligos, kuri silpnina raumenis ir vadinama amiotrofine sonine skleroze.
rilutek has been prescribed by your doctor for a disease of the nervous system affecting your muscle strength called amyotrophic lateral sclerosis.
마지막 업데이트: 2008-03-04
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
klinikiniais tyrimais rodyta, kad rilutek prailgina lateraline amiotrofine skleroze serganci pacient isgyvenamo laikotarpio trukm (zr.
clinical trials have demonstrated that rilutek extends survival for patients with als (see section 5.1) .
마지막 업데이트: 2008-03-04
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
chmp nusprendė, kad riluzole zentiva nauda yra didesnė už jo keliamą riziką siekiant pailginti amiotrofine lateraline skleroze sergančių pacientų gyvenimo trukmę arba laiką iki atsirandant būtinybei pradėti mechaninę plaučių ventiliaciją.
the chmp decided that riluzole zentiva’s benefits are greater than its risks to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
klinikiniais tyrimais įrodyta, kad rilutek prailgina lateraline amiotrofine skleroze sergančių pacientų išgyvenamo laikotarpio trukmę (žr. 5.1 skyrių).
clinical trials have demonstrated that rilutek extends survival for patients with als (see section 5.1).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
iii fazės klinikinio tyrimo, kuriame dalyvavo lateraline amiotrofine skleroze sirgę ir riluzolu gydyti pacientai, metu dažniausiai pasireiškusios nepageidaujamos reakcijos buvo astenija, pykinimas ir kepenų funkcijos rodmenų koncentracijos nukrypimas nuo normos.
in phase iii clinical studies conducted in als patients treated with riluzole, the most commonly reported adverse reactions were asthenia, nausea and abnormal liver function tests.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
dozei parinkti skirto tyrimo metu 959 lateraline amiotrofine skleroze sergantys pacientai buvo atsitiktinai paskirstyti į 4 grupes (vartojo 50 mg, 100 mg ar 200 mg riluzolo per parą arba placebą) ir stebėti 18 mėnesių.
in a dose-ranging trial, 959 patients with als were randomised to one of four treatment groups: riluzole 50, 100, 200 mg/day, or placebo and were followed-up for 18 months.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질: